Preoperative neoadjuvant chemoradiotherapy provides borderline resectable thoracic esophageal cancer with equivalent treatment results as clinically T3 thoracic esophageal cancer

AIM: Because the optimal treatment strategy for borderline resectable (cT3br) thoracic esophageal cancer patients remains unclear, it is of great interest whether preoperative neoadjuvant therapy for cT3br could achieve results comparable to those seen with resectable T3 cancer (cT3r). We speculated...

Descripción completa

Detalles Bibliográficos
Autores principales: Wakita, Akiyuki, Motoyama, Satoru, Sato, Yusuke, Nagaki, Yushi, Fujita, Hiromu, Kemuriyama, Kohei, Hayashi, Kenjiro, Imai, Kazuhiro, Nanjo, Hiroshi, Minamiya, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623951/
https://www.ncbi.nlm.nih.gov/pubmed/37927919
http://dx.doi.org/10.1002/ags3.12706

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10623951/
https://www.ncbi.nlm.nih.gov/pubmed/37927919
http://dx.doi.org/10.1002/ags3.12706

Ejemplares similares